Kalvista Pharmaceuticals, Inc.
KALV
Revenue
13.69M
▲12.29M▲878.00%
2 Months ChangeAssets
339.93M
▲124.43M▲57.74%
2 Months ChangeLiabilities
322.93M
▲192.48M▲147.54%
9 Months ChangeFree Cash Flow
-54.79M
▼-14.55M▼-36.16%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-01-08
Form 8-K
ID: 0001193125-26-007801
2025-11-10
Form 10-Q
ID: 0001193125-25-274442
2025-11-10
Form 8-K
ID: 0001193125-25-274405
2025-10-06
Form 8-K
ID: 0001193125-25-230906
2025-10-02
Form 8-K
ID: 0001193125-25-227478
2025-09-29
Form 8-K
ID: 0001193125-25-223262
2025-09-11
Form 10-Q
ID: 0001193125-25-200757
2025-09-11
Form 8-K
ID: 0001193125-25-200742
2025-08-21
Form 8-K
ID: 0001193125-25-185382
2025-07-10
Form 8-K
ID: 0001193125-25-157382